Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:600-607, doi:10.1016/j.jacc.2008.08.079
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mullens, W.
Right arrow Articles by Tang, W.H. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mullens, W.
Right arrow Articles by Tang, W.H. W.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: CARDIAC RESYNCHRONIZATION THERAPY

Persistent Hemodynamic Benefits of Cardiac Resynchronization Therapy With Disease Progression in Advanced Heart Failure

Wilfried Mullens, MD, Tanya Verga, RN, Richard A. Grimm, DO, FACC, Randall C. Starling, MD, MPH, FACC, Bruce L. Wilkoff, MD, FACC and W.H. Wilson Tang, MD, FACC*

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio

Manuscript received May 5, 2008; revised manuscript received August 29, 2008, accepted August 31, 2008.

* Reprint requests and correspondence: Dr. W. H. Wilson Tang, Section of Heart Failure and Cardiac Transplantation Medicine, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, Ohio 44195 (Email: tangw{at}ccf.org).

Objectives: Our aim was to determine the potential hemodynamic contributions of cardiac resynchronization therapy (CRT) in patients admitted for advanced decompensated heart failure.

Background: CRT restores synchrony of the heart resulting in hemodynamic support that can facilitate the reversal of left ventricular (LV) remodeling in some patients.

Methods: A total of 40 consecutive patients with advanced decompensated heart failure and CRT implanted >3 months, admitted due to hemodynamic derangements, underwent simultaneous comprehensive echocardiographic and invasive hemodynamic evaluation under different CRT settings.

Results: All patients (mean LV ejection fraction 22 ± 7%, LV end-diastolic volume 323 ± 140 ml, 40% ischemic) had experienced progressive cardiac remodeling despite adequate LV lead positions and continuous biventricular pacing. A significant worsening of hemodynamics was observed immediately when CRT was programmed OFF in the majority (88%) of patients (systolic blood pressure: 105 ± 12 mm Hg to 98 ± 13 mm Hg; pulmonary capillary wedge pressure: 17 ± 6 mm Hg to 21 ± 7 mm Hg; cardiac output: 4.6 ± 1.4 l/min·m2 to 4.0 ± 1.1 l/min·m2; all p < 0.001). Worsening of hemodynamics coincided with reappearance of significant electrical (QRS width 161 ± 29 ms to 202 ± 39 ms, p < 0.001) and intraventricular mechanical dyssynchrony (15 ± 26 ms to 57 ± 41 ms, p < 0.001), together with a significant reduction in diastolic filling time (377 ± 138 ms to 300 ± 118 ms, p < 0.001).

Conclusions: Despite progressive cardiac remodeling and decompensation, chronic CRT continues to provide hemodynamic augmentation in the failing heart in most patients. Our data suggest that disease progression may not be explained by diminished beneficial hemodynamic contributions of successful resynchronization.

Key Words: heart failure • hemodynamics • pacing • remodeling

Abbreviations and Acronyms
  AV = atrioventricular
  CO = cardiac output
  CRT = cardiac resynchronization therapy
  CVP = central venous pressure
  LV = left ventricle/ventricular
  NYHA = New York Heart Association
  PCWP = pulmonary capillary wedge pressure


Related Articles

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?
John G.F. Cleland, Luigi Tavazzi, Jean-Claude Daubert, Ahmed Tageldien, and Nick Freemantle
J. Am. Coll. Cardiol. 2009 53: 608-611. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32. [Full Text] [PDF]



This article has been cited by other articles:


Home page
EuropaceHome page
P. W.X. Foley, F. Leyva, and M. P. Frenneaux
What is treatment success in cardiac resynchronization therapy?
Europace, November 1, 2009; 11(suppl_5): v58 - v65.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. J. van Bommel, J. J. Bax, W. T. Abraham, E. S. Chung, L. A. Pires, L. Tavazzi, P. J. Zimetbaum, B. Gerritse, N. Kristiansen, and S. Ghio
Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis
Eur. Heart J., October 2, 2009; 30(20): 2470 - 2477.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. G.F. Cleland, L. Tavazzi, J.-C. Daubert, A. Tageldien, and N. Freemantle
Cardiac resynchronization therapy are modern myths preventing appropriate use?
J. Am. Coll. Cardiol., February 17, 2009; 53(7): 608 - 611.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement